ZA978625B - Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium. - Google Patents

Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium.

Info

Publication number
ZA978625B
ZA978625B ZA9708625A ZA978625A ZA978625B ZA 978625 B ZA978625 B ZA 978625B ZA 9708625 A ZA9708625 A ZA 9708625A ZA 978625 A ZA978625 A ZA 978625A ZA 978625 B ZA978625 B ZA 978625B
Authority
ZA
South Africa
Prior art keywords
swellable
aqueous medium
matrix
active compound
pharmaceutical active
Prior art date
Application number
ZA9708625A
Other languages
English (en)
Inventor
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA978625B publication Critical patent/ZA978625B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9708625A 1996-09-28 1997-09-26 Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium. ZA978625B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19640062A DE19640062B4 (de) 1996-09-28 1996-09-28 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff

Publications (1)

Publication Number Publication Date
ZA978625B true ZA978625B (en) 1998-03-26

Family

ID=7807265

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708625A ZA978625B (en) 1996-09-28 1997-09-26 Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium.

Country Status (23)

Country Link
US (1) US6238698B1 (cs)
EP (1) EP0946150B1 (cs)
JP (1) JP2001504807A (cs)
KR (1) KR100493139B1 (cs)
CN (1) CN1139378C (cs)
AT (1) ATE213933T1 (cs)
AU (1) AU724802B2 (cs)
CA (1) CA2260845C (cs)
CZ (1) CZ291258B6 (cs)
DE (2) DE19640062B4 (cs)
DK (1) DK0946150T3 (cs)
ES (1) ES2174296T3 (cs)
HU (1) HU227865B1 (cs)
IL (1) IL129171A (cs)
MY (1) MY130959A (cs)
NO (1) NO991477L (cs)
NZ (1) NZ333401A (cs)
PL (1) PL188392B1 (cs)
PT (1) PT946150E (cs)
SI (1) SI0946150T1 (cs)
SK (1) SK282709B6 (cs)
WO (1) WO1998013028A1 (cs)
ZA (1) ZA978625B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
WO2007048219A2 (en) * 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
PT1931346E (pt) * 2005-09-09 2012-08-14 Angelini Labopharm Llc Composição de trazodona para administração uma vez por dia
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
CA2750421C (en) 2008-11-27 2016-10-18 B.R.A.I.N. Biotechnology Research And Information Network Ag Surface active proteins as excipients in solid pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
ATE137668T1 (de) * 1992-07-24 1996-05-15 Labopharm Inc Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4416926C2 (de) 1994-05-13 2000-01-13 Lohmann Therapie Syst Lts Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
WO2007095324A1 (en) 2006-02-14 2007-08-23 The Procter & Gamble Company Personal care compositions comprising responsive particles

Also Published As

Publication number Publication date
HUP9903115A3 (en) 2000-03-28
KR100493139B1 (ko) 2005-06-02
PT946150E (pt) 2002-08-30
SK38799A3 (en) 2000-03-13
NO991477D0 (no) 1999-03-26
CZ101399A3 (cs) 1999-07-14
AU4619397A (en) 1998-04-17
PL188392B1 (pl) 2005-01-31
WO1998013028A1 (de) 1998-04-02
EP0946150B1 (de) 2002-03-06
KR20010029533A (ko) 2001-04-06
JP2001504807A (ja) 2001-04-10
CN1231600A (zh) 1999-10-13
DE19640062A1 (de) 1998-04-09
MY130959A (en) 2007-07-31
ATE213933T1 (de) 2002-03-15
ES2174296T3 (es) 2002-11-01
DE59706576D1 (de) 2002-04-11
CN1139378C (zh) 2004-02-25
CZ291258B6 (cs) 2003-01-15
SI0946150T1 (en) 2002-08-31
IL129171A0 (en) 2000-02-17
EP0946150A1 (de) 1999-10-06
HU227865B1 (en) 2012-05-29
NO991477L (no) 1999-03-26
US6238698B1 (en) 2001-05-29
NZ333401A (en) 1999-10-28
CA2260845A1 (en) 1998-04-02
CA2260845C (en) 2005-11-22
IL129171A (en) 2001-11-25
DE19640062B4 (de) 2006-04-27
SK282709B6 (sk) 2002-11-06
PL332577A1 (en) 1999-09-27
HUP9903115A2 (hu) 2000-02-28
DK0946150T3 (da) 2002-06-24
AU724802B2 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
CA2199249A1 (en) Laminated tablet with pointed core
EP0235718A3 (en) Granule remaining in stomach
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
ATE240719T1 (de) Pharmazeutische tablette mit verzögerter freisetzung, enthaltend eine matrix aus quervernetzter amylose und hydroxypropyl methylzellulose
ITMI922617A1 (it) Forme matriciali multistrato per il rilascio controllato di principi attivi
EP0147780A3 (en) Drug delivery device
AU1023788A (en) Therapeutic system for sparingly soluble active ingredients
AU4989997A (en) Soluble form osmotic dose delivery system
JPH11248943A5 (cs)
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
ZA978625B (en) Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium.
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
CA2283408A1 (en) Swallow tablet comprising paracetamol
EP0968712A4 (en) Patch containing Felbinac
EP0070127A3 (en) Tablets
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
CA2204157A1 (en) Children-proof package for active substance-containing plaster
EP1020182A3 (en) A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
ES8603262A1 (es) Perfeccionamientos en formas farmaceuticas solidas para uso oral
SE9501670D0 (sv) Omläggningsset
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény
AU4015097A (en) Transdermal therapeutic system having an active compound combination comprising oestriol
谭国律 The Congruence Canonical Form of Positive Semidefinite Matrix
CA2198092A1 (en) Transdermal therapeutic system with protection against hydrolysis
CA2197867A1 (en) Oestradiol transdermal therapeutic system comprising hygroscopic additives